Best Biotech Stocks To Buy Under $10 May 2026
Recent Phase 1b study results for its Crohn's disease treatment showed a favorable safety profile with no serious adverse events. :
: Highlighted for strengthening its global reach through strategic deals, such as the one with Kyowa Kirin. best biotech stocks to buy under $10
: Noted for its inhaled therapy for pulmonary arterial hypertension and its recent pursuit of FDA pediatric approval. Recent Phase 1b study results for its Crohn's
The primary catalyst is upcoming clinical data for ulcerative colitis, expected in the second half of 2027. The primary catalyst is upcoming clinical data for
The company recently expanded its pipeline by acquiring DMX-200 for kidney disease.
Searching for biotech stocks under $10 reveals several companies with strong analyst backing and significant upcoming catalysts. As of late 2025 and early 2026, the following stocks are frequently highlighted by financial experts for their growth potential: Top Rated Biotech Stocks Under $10 :